<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <title>HELIXMITH</title>
    <link type="text/css" rel="stylesheet" href="css/reset.css" />
    <link type="text/css" rel="stylesheet" href="css/style.css" />
    <link type="text/css" rel="stylesheet" href="css/animate.css" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>

<body>
    <!--wrapper-->
    <div class="wrapper">
        <!--headNavigation-->
        <div class="headNavigation headImage3 wow fadeIn">
            <!--inside-->
            <div class="inside">
                <!--menus-->
                <div class="menus">
                    <!--logo-->
                    <div class="left">
                        <a href="index.html">
                            <img src="img/logo.svg">
                        </a>
                    </div>
                    <!--//logo-->
                    <div class="right">
                        <ul class="pc">
                            <li>
                                <a href="about_1.html">
                                    About Helixmith
                                </a>
                                <div class="dropdown-content">
                                    <div class="box">
                                        <a href="about_1.html">
                                            <p>
                                                Our Company
                                            </p>
                                        </a>
                                        <a href="about_2.html">
                                            <p>
                                                Team Member
                                            </p>
                                        </a>
                                        <a href="about_3.html">
                                            <p>
                                                Locations
                                            </p>
                                        </a>
                                    </div>
                                </div>
                            </li>
                            <li>
                                <a href="vm202.html">
                                    Engensis
                                </a>
                                <div class="dropdown-content">
                                    <div class="box">
                                        <a href="vm202.html#first">
                                            <p>
                                                Overview
                                            </p>
                                        </a>
                                        <a href="vm202_dpn.html#first">
                                            <p>
                                                Engensis in DPN
                                            </p>
                                        </a>
                                        <a href="vm202_dpn.html#second">
                                            <p>
                                                Engensis in DFU
                                            </p>
                                        </a>
                                        <a href="vm202_dpn.html#third">
                                            <p>
                                                Engensis in ALS
                                            </p>
                                        </a>
                                        <a href="vm202_dpn.html#fourth">
                                            <p>
                                                Engensis in CAD
                                            </p>
                                        </a>
                                    </div>
                                </div>
                            </li>
                            <li>
                                <a href="platform.html">
                                    Early Phase Programs
                                </a>
                                <div class="dropdown-content">
                                    <div class="box">
                                        <a href="platform.html#first">
                                            <p>
                                                Neuromyon
                                            </p>
                                        </a>
                                        <a href="platform.html#second">
                                            <p>
                                                Chimericsmith
                                            </p>
                                        </a>
                                        <a href="platform.html#second">
                                            <p>
                                                Oncosmith
                                            </p>
                                        </a>
                                    </div>
                                </div>
                            </li>
                            <li>
                                <a href="botanicals.html">
                                    CERESMITH
                                </a>
                            </li>
                            <li>
                                <a href="#">
                                    News
                                </a>
                                <div class="dropdown-content">
                                    <div class="box">
                                        <a href="#">
                                            <p>
                                                News/Investors
                                            </p>
                                        </a>
                                    </div>
                                </div>
                            </li>
                            <li>
                                <a href="careers.html">
                                    Careers
                                </a>
                            </li>
                        </ul>
                        <ul class="mobile displayFlex">
                            <li>
                                <img src="img/mobile_menu_ico.svg" id="showPanel" />
                            </li>
                        </ul>
                    </div>
                </div>
                <!--//menus-->
                <!--content-->
                <div class="content subContent">
                    <h1 class="headText">
                        Early Phase Programs
                    </h1>
                </div>
                <!--//content-->
            </div>
            <!--//inside-->
        </div>
        <!--//headNavigation-->
        <!--1-->
        <!-- <div class="vm202Section marginTop50" id="first">
            <div class="first">
                
                <div class="text wow fadeIn">
                    <p>
                        Helixmith is building an integrated gene therapy platform utilizing cutting-edge DNA crafting
                        skills
                        we have accumulated. We strive to create new gene therapies for patients with intractable
                        neuromuscular diseases, muscle diseases and cancers. Learn more about our platform below.
                    </p>
                </div>
                
            </div>
        </div> -->
        <!--//1-->
        <!--1-->
        <div class="vm202Section marginTop50">
            <div class="first">
                <!-- headText -->
                <div class="text wow fadeIn">
                    <h1 class="headText">
                        Neuromyon
                    </h1>
                </div>
                <!-- //headText -->
                <!-- iconBox -->
                <!-- <div class="iconBox">
                    <img src="img/early_phase_ico1.svg" />
                </div> -->
                <!-- //iconBox -->
                <!--text-->
                <div class="text wow fadeIn">
                    <p>
                        With our proprietary plasmid DNA technology (pCK vector) and AAV vector technology, we aim to
                        treat
                        neuromuscular and muscle diseases. Our reengineered vectors are capable of reaching central
                        nervous
                        system or internal organs where it is difficult to reach with plasmid DNA.
                    </p>
                    <p>
                        Neuromyon program intends to treat neuromuscular diseases based on our proprietary plasmid DNA
                        technology (pCK vector) and AAV vector technology.
                    </p>
                    <p>
                        Our plasmid DNA technology allows a maximized gene therapy protein expression profile with the
                        possibility of mass production. Its excellent safety profile and protein expression levels can
                        expand its target indications with carefully genes.
                    </p>
                    <p>
                        Based on technologies and IPs we have secured over the past years, we are building new platforms
                        with
                        even higher expression level and developing next generation plasmid DNA medicines equipped with
                        newly optimized therapeutic genes.
                    </p>
                    <p>
                        AAV vector is another area of focus in exploring treatment options for intractable diseases, as
                        it
                        can effectively deliver therapeutic genes to body parts such as the central nervous system or
                        internal organs that may be difficult to reach with plasmid DNA.
                    </p>
                </div>
                <!--//text-->
                <!--image-->
                <div class="vm202Table wow fadeIn" data-wow-delay=".2s">
                    <img src="img/platform_img1.svg" class="pc" />
                    <img src="img/platform_img1_mobile.svg" class="mobile" />
                </div>
                <!--//image-->
            </div>
        </div>
        <!--//1-->
        <!--divider-->
        <div class="divider"></div>
        <!--//divider-->
        <!--2-->
        <div class="vm202Section marginTop50" id="second">
            <div class="first">
                <!-- headText -->
                <div class="text wow fadeIn">
                    <h1 class="headText">
                        Chimericsmith
                    </h1>
                </div>
                <!-- //headText -->
                <!-- iconBox -->
                <!-- <div class="iconBox">
                    <img src="img/early_phase_ico2.svg" />
                </div> -->
                <!-- //iconBox -->
                <!--text-->
                <div class="text wow fadeIn">
                    <p>
                        Having expertise in retroviral based ex-vivo gene modification, we are expanding our research to
                        cell mediated gene therapy, especially solid tumor targeting CAR-T cell technology. Currently,
                        we have 4 research-phase pipelines, one being licensed out to Bluebird bio.
                    </p>
                    <p>
                        Chimericsmith is Helixmith’s Chimeric Antigen Receptor (CAR) program that incorporates years of
                        hands-on experience from ex vivo gene therapy clinical trial involving hematopoietic stem cells
                        as early as a decade ago, through which Helixmith acquired retroviral vector platform and ex
                        vivo gene transfer technology essential to CAR-T therapies.
                    </p>
                    <p>
                        Helixmith’s first CAR candidate based on its core technology was licensed out to Bluebird bio in
                        2015. In retroviral vector technology, we hold our own proprietary technology and IPs for
                        retroviral vectors that have high gene expression level and excellent safety profile, with no
                        potential of creating replication-competent retrovirus.
                    </p>
                </div>
                <!--//text-->
                <!--image-->
                <div class="vm202Table wow fadeIn" data-wow-delay=".2s">
                    <img src="img/platform_img2.svg" class="pc" />
                    <img src="img/platform_img2_mobile.svg" class="mobile" />
                </div>
                <!--//image-->
            </div>
        </div>
        <!--//2-->
        <!--divider-->
        <div class="divider"></div>
        <!--//divider-->
        <!--3-->
        <div class="vm202Section marginTop50" id="third">
            <div class="first">
                <!-- headText -->
                <div class="text wow fadeIn">
                    <h1 class="headText">
                        Oncosmith
                    </h1>
                </div>
                <!-- //headText -->
                <!-- iconBox -->
                <!-- <div class="iconBox">
                    <img src="img/early_phase_ico3.svg" />
                </div> -->
                <!-- //iconBox -->
                <!--text-->
                <div class="text wow fadeIn">
                    <p>
                        We are investigating new and innovative approaches to help cure cancer patients, utilizing our
                        plasmid DNA and recombinant protein technology. 2 pipelines are successfully undergoing Phase I
                        and
                        II clinical trials in China and Korea.
                    </p>
                    <p>
                        Oncosmith is a program that intends to help cancer patients, based on our plasmid DNA and
                        recombinant protein technology.
                    </p>
                    <p>
                        A therapeutic cancer vaccine program, VM206 targets HER2/neu positive breast or ovarian cancer.
                        HER2/neu is a well-known tumor-associated antigen that is highly expressed in breast, ovarian,
                        and
                        gastric cancer, over-expressed in about 30% of breast cancers and strongly associated with poor
                        prognosis. VM206 can elicit an immune response to HER2/neu, resulting in a reduction in the
                        growth
                        and recurrence rate of breast or ovarian cancer. The Phase I clinical trial of VM206 has been
                        completed in Korea.
                    </p>
                    <p>
                        A re-engineered form of interleukin 11 (IL-11), VM501 targets chemotherapy-induced
                        thrombocytopenia
                        (CIT). Compared to existing recombinant IL-11 medicine for the disease, VM501 is more effective
                        in
                        low dosage with better safe profile. In Phase I and II clinical trials conducted in China, VM501
                        showed significant therapeutic effects with without severe adverse effects.
                    </p>
                </div>
                <!--//text-->
                <!--image-->
                <div class="vm202Table wow fadeIn" data-wow-delay=".2s">
                    <img src="img/platform_img3.svg" class="pc" />
                    <img src="img/platform_img3_mobile.svg" class="mobile" />
                </div>
                <!--//image-->
            </div>
        </div>
        <!--//3-->
        <!--divider-->
        <div class="divider"></div>
        <!--//divider-->
        <!--footer-->
        <div class="footer">
            <div class="menus">
                <!-- <a href="#">
                    Privacy Policy
                </a>
                /
                <a href="careers.html">
                    Careers
                </a> -->
                <img src="img/logo_footer.svg" />
            </div>
            <div class="info">
                <div class="left">
                    5th Fl. Bldg. 203 Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 00826, Republic of
                    Korea<br>
                    10390 Pacific Center Ct., San Diego, CA, 92121, US<br>
                    Tel. 82.2.2102.7200 / Fax. 82.2.873.8022 / Email. hxcontact@helixmith.com
                </div>
                <div class="right">
                    Copyright © 2019 Helixmith Co., Ltd. All Rights Reserved.
                </div>
            </div>
        </div>
        <!--//footer-->
    </div>
    <!--//wrapper-->
    <!--mobile Menu-->
    <div id="mobileMenu">
        <ul>
            <li>
                <a href="about_1.html">
                    Our Company
                </a>
            </li>
            <li>
                <a href="about_2.html">
                    Team Member
                </a>
            </li>
            <li>
                <a href="about_3.html">
                    Locations
                </a>
            </li>
            <li>
                <a href="vm202.html">
                    Engensis Overview
                </a>
            </li>
            <li>
                <a href="vm202_dpn.html">
                    Engensis
                </a>
            </li>
            <li>
                <a href="platform.html">
                    Platform & Technology
                </a>
            </li>
            <li>
                <a href="botanicals.html">
                    CERESMITH
                </a>
            </li>
            <li>
                <a href="#">
                    News
                </a>
            </li>
            <li>
                <a href="careers.html">
                    Careers
                </a>
            </li>
            <li>
                <div class="button" id="hidePanel">
                    <img src="img/close_ico.svg" />
                </div>
            </li>
        </ul>
    </div>
    <!--//mobile Menu-->
    <!--js-->
    <script src="js/wow.js"></script>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>

    <script>
        wow = new WOW(
            {
                animateClass: 'animated',
                offset: 100,
                callback: function (box) {
                    console.log("WOW: animating <" + box.tagName.toLowerCase() + ">")
                }
            }
        );
        wow.init();

        $(document).ready(function () {

            $("#showPanel").click(function () {
                $("#mobileMenu").show();
            });

            $("#hidePanel").click(function () {
                $("#mobileMenu").hide();
            });

        });
    </script>
    <!--//js-->
</body>

</html>